Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Progesterona para el síndrome premenstrual

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD003415.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 18 octubre 2006see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Ginecología y fertilidad

Copyright:
  1. Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Olive Ford

    Correspondencia a: Not applicable, Not applicable, South Petherton, UK

    [email protected]

  • Anne Lethaby

    Section of Epidemiology & Biostatistics, School of Population Health,University of Auckland, Auckland, New Zealand

  • Helen Roberts

    Obstetrics & Gynaecology, National Women's Hospital, Auckland, New Zealand

Contributions of authors

Ben Mol made suggestions during the writing of the protocol, helped with the extraction of data from the published reports of trials and contributed to the development of the methods.

Helen Roberts was the Clinical Adviser and contributed to all sections especially in the final writing.

Anne Lethaby advised during the latter part of the writing of the review particularly on the Description of Studies and Discussion.

Olive Ford took the lead in writing the protocol and review, performed initial searches of databases for trials, was involved in selecting trials for inclusion, performed independent data extraction and quality assessment of the included trials, and was responsible for statistical analysis and interpretation of the data.

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • none detailed by review author, Not specified.

Declaraciones de interés

disponible en

Ninguno conocido.

Agradecimientos

disponible en

Se agradece a Dr Andersch,Professor Lorrainee Dennerstein, Dr E. W. Freeman, Dr P. J. Magill, Dr Andrea Rapkin, Dr S. S. Shapiro, Dr S. L. Smith y Dr Wendy Vanselow por responder a las preguntas sobre los métodos utilizados en sus ensayos

Ferring Pharmaceuticals, Berkshire, UK, Nordic Pharma UK Ltd y Wyeth Pharmaceuticals UK respondieron a las preguntas sobre los productos de progesterona y el material no publicado.

El personal de Yeovil Central Branch of Somerset County Council Library tuvo mucho cuidado al realizar búsquedas en las revistas confusas y los préstamos entre las bibliotecas. Rose Elliot, Jill Lang, Jean Robinson y Dawn Robson merecen un agradecimiento especial por su trabajo.

También se agradece a Jean Hill de la Academy Library, Somerset Academy‐Yeovil, Yeovil District Hospital.

Se agradece el apoyo suministrado por el personal del Grupo de Trastornos Menstruales y Subfertilidad, especialmente a Michelle Proctor, anterior coordinadores del Grupo de revisión y a los coordinadores de búsqueda.

Version history

Published

Title

Stage

Authors

Version

2012 Mar 14

Progesterone for premenstrual syndrome

Review

Olive Ford, Anne Lethaby, Helen Roberts, Ben Willem J Mol

https://doi.org/10.1002/14651858.CD003415.pub4

2009 Apr 15

Progesterone for premenstrual syndrome

Review

Olive Ford, Anne Lethaby, Helen Roberts, Ben Willem J Mol

https://doi.org/10.1002/14651858.CD003415.pub3

2006 Oct 18

Progesterone for premenstrual syndrome

Review

Olive Ford, Anne Lethaby, Helen Roberts

https://doi.org/10.1002/14651858.CD003415.pub2

2006 Jul 19

Progesterone for premenstrual syndrome

Protocol

Olive Ford, Ben Mol, Helen Roberts

https://doi.org/10.1002/14651858.CD003415